المؤلفون: Rauwerdink P; Department of Surgery, St. Antonius Hospital, Nieuwegein, Netherlands. Electronic address: p.rauwerdink@antoniusziekenhuis.nl., van de Vlasakker VCJ; Department of Surgery, Catharina Hospital, Eindhoven, Netherlands., Wassenaar ECE; Department of Surgery, St. Antonius Hospital, Nieuwegein, Netherlands., Rovers KP; Department of Surgery, Catharina Hospital, Eindhoven, Netherlands., Los M; Department of Medical Oncology, St. Antonius Hospital, Nieuwegein, Netherlands., Herbschleb KH; Department of Medical Oncology, St. Antonius Hospital, Nieuwegein, Netherlands., Creemers GM; Department of Medical Oncology, Catharina Hospital, Eindhoven, Netherlands., Thijs AMJ; Department of Medical Oncology, Catharina Hospital, Eindhoven, Netherlands., Raicu MG; Department of Pathology DNA, St. Antonius Hospital, Nieuwegein, Netherlands., Huysentruyt CJR; Department of Pathology, Catharina Cancer Institute - Eurofins PAMM, Eindhoven, Netherlands., van der Hoeven EJRJ; Department of Radiology, St. Antonius Hospital, Nieuwegein, Netherlands., Nederend J; Department of Radiology, Catharina Hospital, Eindhoven, Netherlands., Peeters RYM; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, Netherlands., Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, Netherlands; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Elias SG; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Fijneman RJA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands., Constantinides A; Lab Translational Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, Netherlands., Kranenburg O; Lab Translational Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, Netherlands., Burger PWA; Department of Surgery, Catharina Hospital, Eindhoven, Netherlands., Nienhuijs SW; Department of Surgery, Catharina Hospital, Eindhoven, Netherlands., Wiezer RJ; Department of Surgery, St. Antonius Hospital, Nieuwegein, Netherlands., Lurvink RJ; Department of Surgery, Catharina Hospital, Eindhoven, Netherlands., de Hingh IHJT; Department of Surgery, Catharina Hospital, Eindhoven, Netherlands; Department of Epidemiology, School for Oncology and Developmental Biology, GROW, Maastricht, Netherlands. Electronic address: ignace.d.hingh@catharinaziekenhuis.nl., Boerma D; Department of Surgery, St. Antonius Hospital, Nieuwegein, Netherlands. Electronic address: d.boerma@antoniusziekenhuis.nl.

المصدر: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2024 Jun 13; Vol. 50 (9), pp. 108487. Date of Electronic Publication: 2024 Jun 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE

المؤلفون: Yildirim H; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands. h.yildirim@amsterdamumc.nl.; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC location University of Amsterdam, 4F De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands. h.yildirim@amsterdamumc.nl., Widdershoven CV; Department of Urology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands., Aarts MJ; Department of Medical Oncology, GROW-School for Oncology and Development Biology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Bex A; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; The Royal Free London NHS Foundation Trust, London, UK.; UCL Division of Surgery and Interventional Science, London, UK., Bloemendal HJ; Department of Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Bochove-Overgaauw DM; Department of Urology, Gelre Hospitals, Apeldoorn/Zutphen, The Netherlands., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, the Netherlands., Herbschleb KH; Department of Internal Medicine, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands., van der Hulle T; Department of Medical Oncology, LUMC, Leiden, the Netherlands., Lagerveld BW; Department of Urology, OLVG, Amsterdam, The Netherlands., van Oijen MG; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC location University of Amsterdam, 4F De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands., Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van Thienen JV; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands., van der Veldt AA; Department of Medical Oncology, Department of Radiology & Nuclear Medicine, Erasmus Medical Center-Cancer Institute, Rotterdam, the Netherlands., Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands., Zeijdner EE; Dutch Oncology Research Platform, Utrecht, The Netherlands., Aben KK; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands., van den Hurk C; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., Zondervan PJ; Department of Urology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands., Bins AD; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC location University of Amsterdam, 4F De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.

المصدر: BMC cancer [BMC Cancer] 2023 Jul 11; Vol. 23 (1), pp. 648. Date of Electronic Publication: 2023 Jul 11.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell*/epidemiology , Carcinoma, Renal Cell*/therapy , Kidney Neoplasms*/epidemiology , Kidney Neoplasms*/therapy, Humans ; Netherlands/epidemiology ; Prospective Studies ; Quality of Life

المؤلفون: de Joode K; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Tol J; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Hamberg P; Department of Oncology, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands., Cloos M; Department of Internal Medicine, Groene Hart Hospital, Gouda, the Netherlands., Kastelijn EA; Department of Pulmonology, St. Antonius Hospital Utrecht/Nieuwegein, Utrecht, the Netherlands., Borgers JSW; Department of Medical Oncology, Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Nuij VJAA; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Klaver Y; Department of Internal Medicine, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands., Herder GJM; Department of Pulmonary Medicine, Meander Medical Center, Amersfoort, the Netherlands., Mutsaers PGNJ; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., Dumoulin DW; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., van Diemen NGJ; Department of Internal Medicine, Bernhoven, Uden, the Netherlands., Libourel EJ; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands., Geraedts EJ; Department of Pulmonology, Groene Hart Hospital, Gouda, the Netherlands., Bootsma GP; Department of Pulmonology, Zuyderland Medical Center, Heerlen, the Netherlands., van der Leest CH; Department of Pulmonology, Amphia Hospital, Breda, the Netherlands., Peerdeman AL; Department of Internal Medicine, Bernhoven, Uden, the Netherlands., Herbschleb KH; Department of Internal Medicine, St. Antonius Hospital Utrecht/Nieuwegein, Utrecht, the Netherlands., Visser OJ; Department of Hematology, Isala Hospital, Zwolle, the Netherlands., Bloemendal HJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., van Laarhoven HWM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Hendriks LEL; Department of Pulmonary Diseases GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands., Beerepoot LV; Department of Internal Medicine, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands., Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands., van den Berkmortel FWPJ; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, the Netherlands., Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Dingemans AC; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., van der Veldt AAM; Department of Medical Oncology and Department of Radiology & Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands. Electronic address: a.vanderveldt@erasmusmc.nl.

مؤلفون مشاركون: DOCC investigators

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jan; Vol. 160, pp. 261-272. Date of Electronic Publication: 2021 Oct 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19/*mortality , Hospitalization/*statistics & numerical data , Life Support Care/*statistics & numerical data , Mortality/*trends , Neoplasms/*mortality , SARS-CoV-2/*isolation & purification , Withholding Treatment/*statistics & numerical data, Aged ; Aged, 80 and over ; COVID-19/epidemiology ; COVID-19/therapy ; COVID-19/virology ; Female ; Humans ; Male ; Middle Aged ; Neoplasms/epidemiology ; Neoplasms/therapy ; Neoplasms/virology ; Netherlands/epidemiology ; Prognosis ; Risk Factors ; Survival Rate

المؤلفون: Janssen JBE; Departments of Medical Oncology., Leow TYS; Departments of Medical Oncology., Herbschleb KH; Department of Internal Medicine, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands., Gijtenbeek JMM; Neurology, Radboud University Medical Center., Boers-Sonderen MJ; Departments of Medical Oncology., Gerritsen WR; Departments of Medical Oncology.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen., Westdorp H; Departments of Medical Oncology.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen.

المصدر: Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2021 Sep 01; Vol. 44 (7), pp. 276-282.

نوع المنشور: Case Reports; Journal Article; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*adverse effects , Guillain-Barre Syndrome/*chemically induced , Immune Checkpoint Inhibitors/*adverse effects , Nivolumab/*adverse effects, Aged ; Fatal Outcome ; Guillain-Barre Syndrome/drug therapy ; Humans ; Immunoglobulins, Intravenous/therapeutic use ; Male ; Melanoma/drug therapy ; Middle Aged ; Prednisolone/therapeutic use ; Prostatic Neoplasms, Castration-Resistant/drug therapy

المؤلفون: Lurvink RJ; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Rauwerdink P; Department of Surgery, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands., Rovers KP; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Wassenaar ECE; Department of Surgery, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands., Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands., Nederend J; Department of Radiology, Catharina Hospital, Eindhoven, The Netherlands., Huysentruyt CJR; Department of Pathology, Catharina Hospital, Eindhoven, The Netherlands., van 't Erve I; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Fijneman RJA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Hoeven EJRJ; Department of Radiology, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands., Seldenrijk CA; Department of Pathology DNA, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands., Constantinides A; Department of Imaging and Cancer, UMC Utrecht, Utrecht, The Netherlands., Kranenburg O; Department of Imaging and Cancer, UMC Utrecht, Utrecht, The Netherlands., Los M; Department of Medical Oncology, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands., Herbschleb KH; Department of Medical Oncology, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands., Thijs AMJ; Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands., Creemers GM; Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands., Burger JWA; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Wiezer MJ; Department of Surgery, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands., Nienhuijs SW; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Boerma D; Department of Surgery, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands., de Hingh IHJT; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands ignace.d.hingh@catharinaziekenhuis.nl.; School for Oncology and Developmental Biology, GROW, Maastricht, The Netherlands.

المصدر: BMJ open [BMJ Open] 2021 Mar 30; Vol. 11 (3), pp. e044811. Date of Electronic Publication: 2021 Mar 30.

نوع المنشور: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/drug therapy , Peritoneal Neoplasms*/drug therapy, Aerosols ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Clinical Trials, Phase II as Topic ; Humans ; Multicenter Studies as Topic ; Oxaliplatin/therapeutic use ; Static Electricity

المؤلفون: Leeneman B; Department of Health Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA Rotterdam, The Netherlands., Uyl-de Groot CA; Department of Health Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA Rotterdam, The Netherlands.; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA Rotterdam, The Netherlands., Aarts MJB; Department of Medical Oncology, Maastricht University Medical Center+, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands., van Akkooi ACJ; Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center, Dr. H. van der Hoffplein 1, 6162 BG Sittard-Geleen, The Netherlands., van den Eertwegh AJM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1118, 1182 DB Amsterdam, The Netherlands., de Groot JWB; Oncology Center Isala, Isala, Dokter van Heesweg 2, 8025 AB Zwolle, The Netherlands., Herbschleb KH; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands., van der Hoeven JJM; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, The Netherlands., van Rijn RS; Department of Internal Medicine, Medical Center Leeuwarden, Henri Dunantweg 2, 8934 AD Leeuwarden, The Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, UMC Utrecht Cancer Center, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands., Ten Tije AJ; Department of Internal Medicine, Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands., van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Vreugdenhil G; Department of Internal Medicine, Maxima MC, Dominee Theodor Fliednerstraat 1, 5631 BM Eindhoven, The Netherlands., Wouters MWJM; Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands., Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Franken MG; Department of Health Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA Rotterdam, The Netherlands.; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA Rotterdam, The Netherlands.

المصدر: Cancers [Cancers (Basel)] 2020 Apr 18; Vol. 12 (4). Date of Electronic Publication: 2020 Apr 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

عنوان ترانسليتريتد: Checkpointremmer geïnduceerde diabetes mellitus.

المؤلفون: Leentjens J; Radboudumc, afd. Interne Geneeskunde, Nijmegen.; Contact: J. Leentjens (jenneke.leentjens@radboudumc.nl)., Olde Bekkink M; Radboudumc, afd. Interne Geneeskunde, Nijmegen., Koot R; Radboudumc, afd. Interne Geneeskunde, Nijmegen., Herbschleb KH; Radboudumc, afd. Interne Geneeskunde, Nijmegen., de Galan BE; Radboudumc, afd. Interne Geneeskunde, Nijmegen.

المصدر: Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2019 Aug 19; Vol. 163. Date of Electronic Publication: 2019 Aug 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Vereniging NTvG Country of Publication: Netherlands NLM ID: 0400770 Publication Model: Electronic Cited Medium: Internet ISSN: 1876-8784 (Electronic) Linking ISSN: 00282162 NLM ISO Abbreviation: Ned Tijdschr Geneeskd Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , Antineoplastic Agents, Immunological/*immunology , Diabetes Mellitus, Type 1/*drug therapy , Diabetes Mellitus, Type 1/*immunology, Cell Cycle Checkpoints/immunology ; Female ; Humans ; Insulin ; Male

المؤلفون: Rovers KP; Department of Surgery, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, Netherlands., Bakkers C; Department of Surgery, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, Netherlands., Simkens GAAM; Department of Surgery, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, Netherlands., Burger JWA; Department of Surgery, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, Netherlands., Nienhuijs SW; Department of Surgery, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, Netherlands., Creemers GM; Department of Medical Oncology, Catharina Hospital, PO Box 1350, 5602, Eindhoven, ZA, Netherlands., Thijs AMJ; Department of Medical Oncology, Catharina Hospital, PO Box 1350, 5602, Eindhoven, ZA, Netherlands., Brandt-Kerkhof ARM; Department of Surgical Oncology, Erasmus Medical Centre, PO Box 2040, 3000, Rotterdam, CA, Netherlands., Madsen EVE; Department of Surgical Oncology, Erasmus Medical Centre, PO Box 2040, 3000, Rotterdam, CA, Netherlands., Ayez N; Department of Surgical Oncology, Erasmus Medical Centre, PO Box 2040, 3000, Rotterdam, CA, Netherlands., de Boer NL; Department of Surgical Oncology, Erasmus Medical Centre, PO Box 2040, 3000, Rotterdam, CA, Netherlands., van Meerten E; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 2040, 3000, Rotterdam, CA, Netherlands., Tuynman JB; Department of Surgery, Amsterdam University Medical Centres, Location VUMC, PO Box 7057, 1007, Amsterdam, MB, Netherlands., Kusters M; Department of Surgery, Amsterdam University Medical Centres, Location VUMC, PO Box 7057, 1007, Amsterdam, MB, Netherlands., Sluiter NR; Department of Surgery, Amsterdam University Medical Centres, Location VUMC, PO Box 7057, 1007, Amsterdam, MB, Netherlands., Verheul HMW; Department of Medical Oncology, Amsterdam University Medical Centres, Location VUMC, PO Box 7057, 1007, Amsterdam, MB, Netherlands., van der Vliet HJ; Department of Medical Oncology, Amsterdam University Medical Centres, Location VUMC, PO Box 7057, 1007, Amsterdam, MB, Netherlands., Wiezer MJ; Department of Surgery, St. Antonius Hospital, PO Box 2500, 3430, Nieuwegein, EM, Netherlands., Boerma D; Department of Surgery, St. Antonius Hospital, PO Box 2500, 3430, Nieuwegein, EM, Netherlands., Wassenaar ECE; Department of Surgery, St. Antonius Hospital, PO Box 2500, 3430, Nieuwegein, EM, Netherlands., Los M; Department of Medical Oncology, St. Antonius Hospital, PO Box 2500, 3430, Nieuwegein, EM, Netherlands., Hunting CB; Department of Medical Oncology, St. Antonius Hospital, PO Box 2500, 3430, Nieuwegein, EM, Netherlands., Aalbers AGJ; Department of Surgical Oncology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Kok NFM; Department of Surgical Oncology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Kuhlmann KFD; Department of Surgical Oncology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Boot H; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Chalabi M; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Kruijff S; Department of Surgery, University Medical Centre Groningen, PO Box 30001, 9700 RB, Groningen, RB, Netherlands., Been LB; Department of Surgery, University Medical Centre Groningen, PO Box 30001, 9700 RB, Groningen, RB, Netherlands., van Ginkel RJ; Department of Surgery, University Medical Centre Groningen, PO Box 30001, 9700 RB, Groningen, RB, Netherlands., de Groot DJA; Department of Medical Oncology, University Medical Centre Groningen, PO Box 30001, 9700, Groningen, RB, Netherlands., Fehrmann RSN; Department of Medical Oncology, University Medical Centre Groningen, PO Box 30001, 9700, Groningen, RB, Netherlands., de Wilt JHW; Department of Surgery, Radboud University Medical Centre, PO Box 9101, 6500, Nijmegen, HB, Netherlands., Bremers AJA; Department of Surgery, Radboud University Medical Centre, PO Box 9101, 6500, Nijmegen, HB, Netherlands., de Reuver PR; Department of Surgery, Radboud University Medical Centre, PO Box 9101, 6500, Nijmegen, HB, Netherlands., Radema SA; Department of Medical Oncology, Radboud University Medical Centre, PO Box 9101, 6500, Nijmegen, HB, Netherlands., Herbschleb KH; Department of Medical Oncology, Radboud University Medical Centre, PO Box 9101, 6500, Nijmegen, HB, Netherlands., van Grevenstein WMU; Department of Surgery, University Medical Centre Utrecht, PO Box 85500, 3508, Utrecht, GA, Netherlands., Witkamp AJ; Department of Surgery, University Medical Centre Utrecht, PO Box 85500, 3508, Utrecht, GA, Netherlands., Koopman M; Department of Medical Oncology, University Medical Centre Utrecht, PO Box 85500, 3508, Utrecht, GA, Netherlands., Haj Mohammad N; Department of Medical Oncology, University Medical Centre Utrecht, PO Box 85500, 3508, Utrecht, GA, Netherlands., van Duyn EB; Department of Surgery, Medisch Spectrum Twente, PO Box 50000, 7500, Enschede, KA, Netherlands., Mastboom WJB; Department of Surgery, Medisch Spectrum Twente, PO Box 50000, 7500, Enschede, KA, Netherlands., Mekenkamp LJM; Department of Medical Oncology, Medisch Spectrum Twente, PO Box 50000, 7500, Enschede, KA, Netherlands., Nederend J; Department of Radiology, Catharina Hospital, PO Box 1350, 5602, Eindhoven, ZA, Netherlands., Lahaye MJ; Department of Radiology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Snaebjornsson P; Department of Pathology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Verhoef C; Department of Surgical Oncology, Erasmus Medical Centre, PO Box 2040, 3000, Rotterdam, CA, Netherlands., van Laarhoven HWM; Department of Medical Oncology, Amsterdam University Medical Centres, Location AMC, PO Box 22660, 1100, Amsterdam, DD, Netherlands., Zwinderman AH; Department of Clinical Epidemiology, Biostatistics & Bioinformatics, Amsterdam University Medical Centres, Location AMC, PO Box 22660, 1100, Amsterdam, DD, Netherlands., Bouma JM; Clinical Trial Department, Netherlands Comprehensive Cancer Organisation (IKNL), PO Box 19079, 3501, Utrecht, DB, Netherlands., Kranenburg O; UMC Utrecht Cancer Centre, University Medical Centre Utrecht, PO Box 85500, 3508, Utrecht, GA, Netherlands., van 't Erve I; Department of Pathology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Fijneman RJA; Department of Pathology, Netherlands Cancer Institute, PO Box 90203, 1006, Amsterdam, BE, Netherlands., Dijkgraaf MGW; Department of Clinical Epidemiology, Biostatistics & Bioinformatics, Amsterdam University Medical Centres, Location AMC, PO Box 22660, 1100, Amsterdam, DD, Netherlands., Hemmer PHJ; Department of Surgery, University Medical Centre Groningen, PO Box 30001, 9700 RB, Groningen, RB, Netherlands., Punt CJA; Department of Medical Oncology, Amsterdam University Medical Centres, Location AMC, PO Box 22660, 1100, Amsterdam, DD, Netherlands., Tanis PJ; Department of Surgery, Amsterdam University Medical Centres, Location AMC, PO Box 22660, 1100, Amsterdam, DD, Netherlands., de Hingh IHJT; Department of Surgery, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, Netherlands. ignace.d.hingh@catharinaziekenhuis.nl.

مؤلفون مشاركون: Dutch Peritoneal Oncology Group (DPOG), Dutch Colorectal Cancer Group (DCCG)

المصدر: BMC cancer [BMC Cancer] 2019 Apr 25; Vol. 19 (1), pp. 390. Date of Electronic Publication: 2019 Apr 25.

نوع المنشور: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer

مواضيع طبية MeSH: Colorectal Neoplasms/*drug therapy , Colorectal Neoplasms/*surgery , Peritoneal Neoplasms/*drug therapy , Peritoneum/*surgery, Adult ; Bevacizumab/administration & dosage ; Chemotherapy, Adjuvant/adverse effects ; Colorectal Neoplasms/pathology ; Combined Modality Therapy ; Cytoreduction Surgical Procedures/adverse effects ; Disease-Free Survival ; Female ; Fluorouracil/administration & dosage ; Fluorouracil/adverse effects ; Humans ; Leucovorin/administration & dosage ; Leucovorin/adverse effects ; Male ; Middle Aged ; Neoplasm Metastasis ; Oxaliplatin/administration & dosage ; Oxaliplatin/adverse effects ; Perioperative Period ; Peritoneal Neoplasms/pathology ; Peritoneal Neoplasms/secondary ; Peritoneal Neoplasms/surgery ; Peritoneum/drug effects ; Peritoneum/pathology ; Progression-Free Survival ; Quality of Life